跳至主要内容
临床试验/NCT06347835
NCT06347835尚未招募不适用

Biomarker Identification and Nutritional Intervention of Primary Sarcopenia Based on Gut-muscle Axis

Peking Union Medical College Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年4月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
120
试验地点
1
主要终点
Change from Baseline of Appendicular skeletal muscle mass index at 12 weeks

研究概览

简要总结

The loss of skeletal muscle mass and function usually occurs with aging, known as primary sarcopenia. Sarcopenia has a prevalence of 11.6% among the elderly population in China and is closely associated with increased risks of falls, disability, and mortality. Currently, there is a lack of definition criteria for sarcopenia based on biomarkers. The Gut-Muscle Axis hypothesis suggests a complex interplay between gut microbiota and skeletal muscle. Nutritional intervention targeting the gut microbiota potentially plays a significant role in muscle regeneration. Therefore, this study aims to explore the effects of symbiotic and whey protein on muscle, gut microbiota, and clinical outcomes among sarcopenia patients, to provide a reference for further diagnosis and treatment of sarcopenia.

详细描述

This study will last 12 weeks. For the duration of the study, an anticipated total of 120 participants will be randomly assigned to three groups. During the study visits, questionnaires, blood and stool collection, and functional testing will occur. Intention-to-treat analysis (ITT) and per-protocol analysis (PP) will be conducted in statistical analysis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 65 and older
  • Can cooperate with the measurement and questionnaire survey
  • Meets Asian Working Group for Sarcopenia (AWGS) 2019 diagnostic criteria for sarcopenia
  • Obtain informed consent to participate in this study

排除标准

  • Severe complications
  • Suffers from neuromuscular related diseases
  • Have taken antibiotics, probiotics and other medications that may affect the gut microbiota in the last 6 weeks
  • Implants of electronic devices or metal objects in the body

结局指标

主要结局

Change from Baseline of Appendicular skeletal muscle mass index at 12 weeks

时间窗: 12 weeks

Defined as muscle mass (Unit: kg/m2)

Change from Baseline of grip strength at 12 weeks

时间窗: 12 weeks

Defined as muscle strength (Unit: kg)

次要结局

  • Change from Baseline of inflammation status at 12 weeks(12 weeks)
  • Change from Baseline of gut microbiota composition at 12 weeks(12 weeks)
  • Change from Baseline of Short Physical Performance Battery score at 12 weeks(12 weeks)
  • Change from Baseline of gait speed at 12 weeks(12 weeks)
  • Change from Baseline of microbiota-derived metabolites at 12 weeks(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yu Kang, MD

Professor

Peking Union Medical College Hospital

研究点 (1)

Loading locations...

相似试验